UniSuper Management Pty Ltd grew its stake in Teleflex Incorporated (NYSE:TFX - Free Report) by 41.6% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 9,824 shares of the medical technology company's stock after purchasing an additional 2,884 shares during the period. UniSuper Management Pty Ltd's holdings in Teleflex were worth $1,748,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Diamond Hill Capital Management Inc. acquired a new position in Teleflex in the 4th quarter valued at approximately $46,696,000. Magnetar Financial LLC lifted its position in Teleflex by 105.2% in the fourth quarter. Magnetar Financial LLC now owns 421,340 shares of the medical technology company's stock worth $74,990,000 after purchasing an additional 215,961 shares during the period. Cooke & Bieler LP boosted its stake in Teleflex by 22.1% during the fourth quarter. Cooke & Bieler LP now owns 1,078,557 shares of the medical technology company's stock worth $191,962,000 after buying an additional 195,150 shares in the last quarter. Janus Henderson Group PLC increased its holdings in Teleflex by 2.8% in the 3rd quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company's stock valued at $1,329,704,000 after buying an additional 147,147 shares during the period. Finally, Boston Partners raised its stake in shares of Teleflex by 1,561.5% in the 4th quarter. Boston Partners now owns 148,042 shares of the medical technology company's stock valued at $26,351,000 after buying an additional 139,132 shares in the last quarter. Institutional investors own 95.62% of the company's stock.
Wall Street Analyst Weigh In
A number of analysts recently weighed in on the stock. StockNews.com cut shares of Teleflex from a "buy" rating to a "hold" rating in a research note on Friday, February 28th. Wells Fargo & Company cut their target price on Teleflex from $214.00 to $146.00 and set an "equal weight" rating for the company in a research report on Friday, February 28th. Bank of America lowered shares of Teleflex from a "neutral" rating to an "underperform" rating and dropped their price objective for the stock from $235.00 to $140.00 in a report on Tuesday, March 4th. Piper Sandler reaffirmed a "neutral" rating and issued a $140.00 target price (down from $255.00) on shares of Teleflex in a research note on Friday, February 28th. Finally, Truist Financial reduced their target price on shares of Teleflex from $200.00 to $149.00 and set a "hold" rating on the stock in a research report on Monday, March 3rd. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the stock. According to MarketBeat, Teleflex currently has a consensus rating of "Hold" and an average price target of $182.63.
View Our Latest Stock Report on TFX
Teleflex Trading Down 4.3 %
Shares of NYSE:TFX traded down $5.98 during trading on Friday, hitting $132.01. 280,838 shares of the company's stock were exchanged, compared to its average volume of 1,046,549. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The firm has a market cap of $6.12 billion, a P/E ratio of 26.24, a PEG ratio of 1.73 and a beta of 1.21. The firm has a 50-day moving average price of $155.84 and a two-hundred day moving average price of $187.82. Teleflex Incorporated has a 1-year low of $128.55 and a 1-year high of $249.90.
Teleflex (NYSE:TFX - Get Free Report) last posted its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, beating analysts' consensus estimates of $3.86 by $0.03. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The company had revenue of $795.40 million for the quarter, compared to the consensus estimate of $813.24 million. Equities analysts predict that Teleflex Incorporated will post 13.98 earnings per share for the current year.
Teleflex Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Friday, March 7th were given a dividend of $0.34 per share. The ex-dividend date of this dividend was Friday, March 7th. This represents a $1.36 annualized dividend and a dividend yield of 1.03%. Teleflex's payout ratio is currently 95.77%.
About Teleflex
(
Free Report)
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
Featured Articles

Before you consider Teleflex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teleflex wasn't on the list.
While Teleflex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.